GlassScriptPhysician profile
Brian D Greet
NPI 1891011573
$51,669.72
in general payments reported to CMS, 2019-2025
32 companies · $9,675 in 2025
The $9,675 reported for 2025 was more than what 80% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,302 · 2020: $3,012 · 2021: $3,057 · 2022: $4,136 · 2023: $12K · 2024: $14K · 2025: $9,675.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Consulting Fee: $14K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,550 · Travel and Lodging: $916.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15,196.43 |
| Consulting Fee | $13,500.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,550.00 |
| Travel and Lodging | $915.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $16,135.35 | 2019-2025 | Carto 3, Octaray Mapping Catheter, Visitag Surpoint External Processing Unit |
| Abbott Laboratories | $11,026.67 | 2019-2025 | Aveir, Gallant, Agilis Hispro |
| Medical Device Business Services, INC. | $9,750.00 | 2024-2025 | Carto 3 |
| Medtronic, INC. | $8,265.31 | 2021-2025 | Selectsecure, Cobalt Dr Mri Surescan, Mycarelink |
| Boston Scientific Corporation | $2,411.24 | 2019-2025 | Avvigo Guidance System, Farapulse, General - Therapies |
| Medtronic Vascular, INC. | $501.10 | 2019-2020 | |
| Irhythm Technologies, INC. | $448.55 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $397.05 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $335.85 | 2019-2022 | |
| Baxter Healthcare | $286.60 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Biotronik INC. | $259.21 | 2019 | |
| Impulse Dynamics (USA) INC. | $211.51 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $200.42 | 2019-2024 | Eliquis |
| Zoll Respicardia, INC. | $179.21 | 2023 | Remede System |
| Cardiva Medical, INC. | $177.56 | 2022-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade Mvp Vvcs 6-12f |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $134.19 | 2024 | Impella |
| Pfizer INC. | $125.83 | 2020-2024 | |
| Novartis Pharmaceuticals Corporation | $122.34 | 2019 | |
| Cardiofocus, INC. | $97.89 | 2020 | |
| Shockwave Medical, INC | $95.14 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Sanofi-Aventis U.S. LLC | $88.13 | 2021-2023 | |
| Angiodynamics, INC. | $75.41 | 2021 | |
| Altathera Pharmaceuticals LLC | $74.71 | 2021-2023 | Sotalol Hydrochloride |
| Actelion Pharmaceuticals US, INC. | $62.93 | 2019 | |
| Ethicon US, LLC | $43.86 | 2023 | Surgicel Nu-Knit |
| Cvrx, INC. | $38.47 | 2020-2021 | |
| Amgen INC. | $27.39 | 2019 | |
| Genzyme Corporation | $22.13 | 2024 | |
| Elutia, INC. | $21.58 | 2020 | |
| Portola Pharmaceuticals, LLC | $20.35 | 2019 | |
| Saranas, INC. | $18.74 | 2023 | |
| Bardy Diagnostics, INC. | $15.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Greet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.